Cite
HARVARD Citation
Necchi, A. et al. (n.d.). 866PDComprehensive biomarker analyses and updated results of PURE-01 study: Neoadjuvant pembrolizumab (pembro) in muscle-invasive urothelial bladder carcinoma (MIBC). Annals of oncology. p. . [Online].